US Patent 10323037 Aminopyridazinone compounds as protein kinase inhibitors
Patent 10323037 was granted and assigned to Jiangsu Hengrui Medicine on June, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 27, 2018
Date of Patent
June 18, 2019
Patent Applicant
Patent Application Number
15906934
Patent Citations Received
Patent Inventor Names
Qiyue Hu
0
Dong Liu
0
Minsheng Zhang
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10323037 Aminopyridazinone compounds as protein kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.